Development of the Champlain primary care cardiovascular disease prevention and management guideline

L. Montoya(University of Ottawa), Lyall Higginson(University of Ottawa), Andrew Pipe(University of Ottawa), Grant Russell(Monash University), Clare Liddy(University of Ottawa), Laurie Dojeiji, Ayub Akbari(Ottawa Hospital), William Hogg, Sophia Papadakis(University of Ottawa)
Canadian Family Physician
June 1, 2011
Cited by 0

Related Papers

Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women
|JAMA|2002|576
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.
|Circulation|1994|505
High-Dose Epinephrine in Adult Cardiac Arrest
|New England Journal of Medicine|1992|377
Vasopressin versus epinephrine for inhospital cardiac arrest: a randomised controlled trial
|The Lancet|2001|346
Establishing the Minimal Clinically Important Difference for the Hospital Anxiety and Depression Scale in Patients With Cardiovascular Disease
|Journal of Cardiopulmonary Rehabilitation and Prevention|2018|283